New York, NY, May 30, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Regenerative Medicine Market by Product (Gene Therapy, Cell Therapy, Small Molecule & Biologic, and Tissue Engineering), by Material (Biologically-Derived Material, Synthetic Material, Pharmaceuticals, and Genetically Engineered Material), and by Application (Oncology, Cardiovascular, Musculoskeletal, Dermatology, Ophthalmology, Neurology, Wound Healing, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global regenerative medicine market was approximately USD 10.07 billion in 2018 and is expected to generate around USD 48.97 billion by 2025, at a CAGR of around 25.4% between 2019 and 2025.

Regenerative medicine is the practice of substituting, engineering or restoring human organs, tissues, or cells to reinstate or establish their normal roles. Regenerative medicine has the potential to engineer impaired tissues and organs by stimulating the body’s repair mechanisms to heal previously irretrievable organs or tissues. Growing incidences of genetic disorders and chronic diseases, increasing investments by governments in regenerative medicine studies, rising number of companies operating in the regenerative medicine, escalating popularity of stem cell technology, emergence of nanotechnology, rising occurrences of trauma emergencies, various developments in surgical technologies and monitoring devices, deficiency of organs for transplantation, and growing adoption of gene therapies will act as major driving factors in the growth of global regenerative medicine market.

Browse through 55 Tables & 33 Figures spread over 110 Pages and in-depth TOC on “Global Regenerative Medicines Market: By Size, Share, Industry Trends, Growth Analysis and Forecast, 2018–2025”.

Request Free Sample Report of Global Regenerative Medicine Market Report @

However, stringent government regulations, high treatment costs, operative inefficiency, and the lack of awareness will restrict the global regenerative medicine market development.

The global regenerative medicine market is split into product, material, and application. Based on product, the regenerative medicine market includes gene therapy, cell therapy, small molecule and biologic, and tissue engineering. Cell therapy is expected to dominate the market over the estimation time period, as it reinstates the regular functions of organs and tissues. The small molecule and biologic segment are expected to register notable CAGR over the estimated timeframe.

Download Free Report PDF Brochure:

The material segment includes biologically derived material (xenogeneic material and collagen), synthetic material (scaffold, biodegradable synthetic polymer, hydrogel material, and artificial vascular graft material), pharmaceuticals (biologic, DNA sequencing, and small molecule), and genetically engineered material (genetically manipulated cell, deoxyribonucleic acid transfection vector, three-dimensional polymer technology, fibroblast, transgenic, gene-activated matrices, and neural stem cell).  Biologically derived material dominated the application segment in 2018.

The application segment includes oncology, cardiovascular, musculoskeletal, dermatology, ophthalmology, neurology, wound healing, and others. Musculoskeletal is expected to dominate the global market, due to the rising use of regenerative medicines for treating musculoskeletal disorders, growing geriatric population base, and increasing incidences of orthopedic diseases.

Browse the full “Regenerative Medicine Market by Product (Gene Therapy, Cell Therapy, Small Molecule & Biologic, and Tissue Engineering), by Material (Biologically-Derived Material, Synthetic Material, Pharmaceuticals, and Genetically Engineered Material), and by Application (Oncology, Cardiovascular, Musculoskeletal, Dermatology, Ophthalmology, Neurology, Wound Healing, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at

By region, North America will lead the global regenerative medicine market in the future and held over 41% market share in 2018. The U.S. is the leading country in the regenerative medicine market in North America. The U.S. will record notable market progress over the anticipated timeframe, owing to the huge funding for life sciences studies, growing application of personalized medicines, rising cell-based investigation activities, the presence of modern healthcare facilities, and the early acceptance of latest technologies.

Europe will be another important regenerative medicine market, owing to the presence of trained researchers, high research and development investments by top companies, growing geriatric population base, increasing the prevalence of chronic ailments, and favorable reimbursement scenario.

Inquire more about this report before purchase @

The Asia Pacific regenerative medicine market will propagate speedily over the forecast time period, due to the rising incidences of chronic diseases, growing interest in regenerative medicine, increasing R&D related to gene therapy, and escalating occurrences of trauma emergencies. India, China, and Japan are expected to drive the region’s regenerative medicine market.

Latin America will record swift growth over the estimated time period due to increasing investments made by major players in the region, growing awareness regarding applications of regenerative medicine, and favorable efforts taken by the government. The Middle Eastern and African region is predicted to show limited market growth due to the dearth of skilled professionals and the absence of the latest healthcare set-up.

Some key players in the global regenerative medicine market include Zimmer Biomet, Stryker Corporation, Athersys, Medtronic, U.S. Stem Cell, Integra Lifesciences, Organogenesis, Acelity Holdings, CryoLife, and Isto Biologics.

Request customized copy of report @

This report segments the global regenerative medicine market into:

Global Regenerative Medicine Market: By Product

  • Gene Therapy
  • Cell Therapy
  • Small Molecule and Biologic
  • Tissue Engineering

Global Regenerative Medicine Market: By Material

  • Biologically Derived Material
    • Xenogeneic Material
    • Collagen
  • Synthetic Material
    • Scaffold
    • Biodegradable Synthetic Polymer
    • Hydrogel Material
    • Artificial Vascular Graft Material
  • Pharmaceuticals
    • Biologic
    • Small Molecule
    • DNA Sequencing
  • Genetically Engineered Material
    • Genetically Manipulated Cell
    • Deoxyribonucleic Acid Transfection Vector
    • Three-Dimensional Polymer Technology
    • Fibroblast
    • Transgenic
    • Gene-Activated Matrices
    • Neural Stem Cell

Global Regenerative Medicine Market: By Application

  • Oncology
  • Cardiovascular
  • Musculoskeletal
  • Dermatology
  • Ophthalmology
  • Neurology
  • Wound Healing
  • Others

Global Regenerative Medicine Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn:
Follow Us Twitter:

Blog:  | |  | | | | |

Contact Us:

Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651